Although implementation of HIV testing in the emergency department has met with some success, one commonly cited challenge is the consent process. Kiosks offer one potential strategy to overcome this barrier. This pilot cross-sectional survey study examined patient comprehension of opt-in HIV testing consent and acceptability of using a kiosk to provide consent. Subjects were guided through a simulated consent process using a kiosk and then completed a survey of consent comprehension and acceptability of kiosk use. Subjects were 50.3% female, Black (74.4%), and had an education level of high school or less (61.3%). Subjects found the kiosk very easy or easy to use (83.9%) and reported they were very or mostly comfortable using the kiosk to consent to HIV testing (89.4%). Subjects understood the required aspects of consent: HIV testing was voluntary (93.0%, n ¼ 185) and that refusal would not impact their care (98.5%, n ¼ 196; 99.0%, n ¼ 197). Following a simulated consent process, subjects demonstrated a high rate of comprehension about the vital components of HIV testing consent. Subjects reported they were comfortable using the kiosk, found the kiosk easy to use, and reported a positive experience using the kiosk to provide consent for HIV testing.
Emergency departments (EDs) have been increasingly encouraged to take part in the public health strategy of routine HIV screening. 1 The availability of electronic medical records (EMR), updated testing technology, including Clinical Laboratory Improvement Amendments-waived point-of-care (POC) tests, and updated Centers for Disease Control and Prevention (CDC) guidelines for consent language, including optout language, have allowed many EDs to implement routinized HIV screening programs. [2] [3] [4] The rationale for these programs has been extensively described and widely accepted, 5 but practical aspects and barriers of the HIV testing process have been reported in the literature that prevent streamlining and integrating HIV testing into ED clinical operations. 6 From a clinical perspective, the testing process involves many steps including offering HIV testing, obtaining consent, requisitioning the test, and finally performing and resulting the test. Numerous obstacles have been reported in the literature including inadequate/insufficient time for testing, 7 financial burdens, 8 lack of necessary resources, the pretest counseling/consent process, 9, 10 and concerns regarding follow-up for results/linkage to care. [7] [8] [9] [10] Numerous studies specifically cite the lack of time needed to obtain consent for HIV testing, inadequate training of clinical staff, especially with regard to posttest counseling and linkage to care, 11 and patient confusion about opt-out versus opt-in testing. 12 Despite these barriers in consent for HIV testing, several approaches have been evaluated to increase patient comprehension of informed consent. Notably, the removal of written consent per CDC recommendation has been correlated with the increase in San Francisco city-wide testing rate. 13 Furthermore, researchers have begun investigating the effectiveness of new formats and technologies for engaging patients, obtaining consent, and even performing pretest counseling for HIV testing including audiotape and booklet educational materials, 14 video counseling, [15] [16] [17] kiosks, 18 and computer-based tools. 19 Novel technology systems, specifically touch screen kiosks, have been previously investigated by our group in a series of pilot studies as a strategy for engaging interested patients and gathering essential information associated with HIV testing. 20, 21 This pilot study evaluated subjects' comprehension of the HIV opt-in consent process as well as their perceived acceptability regarding the use of touch screen tablet kiosks to assist in the HIV testing process in our ED. Touch screen tablet kiosks were used to provide subjects with a simulated experience of the consent process for HIV testing.
Methods
This study was a cross-sectional survey conducted from March 2014 to July 2014 in an urban academic ED that serves a socioeconomically disadvantaged inner-city population with roughly 70,000 visits per year. Approximately 75% of ED patients identify as African American, 15% are currently or previously injection drug users, and approximately 10-12% of patients are HIV-positive. 22 The ED employs a hybrid, rapid, fourth-generation blood-based and POC HIV testing program that was in place at the time of the study. Trained HIV testing staff work in the ED and provide rapid POC HIV testing to eligible patients who meet the following criteria: aged 18-65 years, not tested within the last three months, not critically ill, able to provide informed consent, and no known HIV diagnosis. Rapid blood-based testing is fully implemented into the clinical workflow and does not involve supplementary HIV testing staff. During the recruitment period of this study, a triage nursebased HIV screening process was implemented at our ED. As part of this process, triage nurses offer HIV testing, consent willing patients, and place an order for an HIV test (rapid oral or blood). HIV testing staff receive an EMR-generated pager for oral tests only and proceed through the testing process.
Study design
The main outcome variable of consent comprehension was assessed via a verbally administered survey, which consisted of three primary true/false questions that measured patient understanding of various aspects of HIV consent. These questions were designed to reflect information required by Maryland state law for opt-in HIV testing consent at that time, including the voluntary nature of HIV testing (question 1) and that refusal of HIV testing would not impact a patient's clinical care (questions 2 and 3). Moreover, two questions (questions 2 and 3) were originally developed as paired items to assess knowledge of the same concept. When subjects answered the nonpaired voluntary nature question incorrectly (question 1), additional follow-up questions were asked by the study coordinator in a yes/no format to further evaluate why subjects answered incorrectly.
Additional outcome variables related to patient acceptability of kiosk use were assessed via a survey that was also verbally administered by the study coordinator. Subjects were asked about their comfort with the tablet kiosk, if they liked using the tablet kiosk, its ease of use, their preference between the tablet kiosk and a healthcare worker, and their opinion of the language and length of the consent materials presented.
Procedure
This study was approved by the Johns Hopkins Medicine Institutional Review Board, application number NA_00047706, and all subjects provided verbal consent prior to any study-related activities.
Study coordinators recruited a convenience sample of ED patients who were eligible for HIV testing and were interested in having an HIV test but had not yet completed consent for HIV testing. Eligibility was determined by screening patients via the EMR for age, HIV diagnosis, HIV testing history, and HIV testing orders. Study coordinators then approached eligible patients at the bedside for enrollment in the study. Consented subjects were given a touch screen tablet kiosk that guided them through a simulated, brief HIV testing consent process. This HIV testing consent process material, developed using Microsoft PowerPoint, Microsoft Access, and Visual Basic, was presented visually through text on screens paired with audio recordings that were Health and Human Services 508 compliant. The mock consent was designed to mimic in-person, verbal consent that is standard of care and included all necessary components of HIV opt-in consent at our institution. Subjects were informed that this simulated consent process was for research purposes only and that they would need to provide institution-approved consent following completion of study-related procedures. Subjects swiped or clicked the touch screen tablet kiosk to progress through a collection of five screens, as seen in Figure 1 .
Following a welcome screen (screen 1), key material for the HIV consent and testing process was presented (screens 2 and 3). Afterward, subjects were asked to 'checkmark' boxes to indicate their understanding of the material (screens 4 and 5).
After check marking the final item on the last screen, subjects completed a structured questionnaire including demographics, HIV opt-in consent comprehension, and Likert-type acceptability of tablet kiosk use (Table 1) . A team of two study coordinators verbally administered the questionnaire and manually recorded patient responses. Administration of the survey was standardized in two ways. First, the primary study coordinator trained and oversaw the second study coordinator for several enrollments. Second, all survey questions were read directly from the data collection forms.
Upon completion of all study-related procedures, subjects were consented and tested by our department's HIV testing staff.
Data analysis
Descriptive and Chi square analyses were conducted to summarize demographic characteristics of subjects, comprehension of consent, and acceptability of kiosk use.
Results
During the study period, 202 subjects were enrolled. Data from three subjects were excluded as they were earlier consented at triage for an HIV test, previously enrolled in the study, or did not provide complete survey data. Overall, data from 199 subjects were included in analyses.
Subjects were approximately evenly distributed between males (49.7%) and females (50.3%) with an average age of approximately 43 years. The majority of subjects were Black/African American (74.4%), had an education level of high school degree or less (60.5%), and stated they had previous experience using a kiosk or tablet-like device (68.8%) ( Table 2) .
Overall, subjects understood the aspects of opt-in consent required by Maryland law and our institution. An overwhelming majority of subjects correctly acknowledged that HIV testing was voluntary (Q1: 93.0%) and that refusal of HIV testing would 
Consent to Test for HIV
• HIV tesƟng is completely voluntary. This means that you do not have to agree to be tested.
• Whether or not you decide to be tested for HIV, your care in the Johns Hopkins ED will NOT be affected (that is, it will stay the same).
Back Next
• If your oral HIV test result is negaƟve, no further tesƟng is necessary today.
• If your oral HIV test result is posiƟve, you will sƟll need a second test to find out if you really have HIV. We will do this by drawing your blood and sending it to the laboratory. The result of that second test will be ready within 2 days. Table 3 ). Of the 14 subjects who answered question 1 incorrectly, 11 then answered a follow-up question correctly, two answered incorrectly, and one was not asked a follow-up question. This reduced the error rate from 7.0 to 1.5% of all subjects. Upon further analysis, a greater portion of these 14 subjects had an education level of high school or less (71.4% compared to 60.5% in the whole sample, p ¼ .307) and reported daily computer use at a lower rate (21.4% compared to 44.9% in the whole sample, p ¼ .088), although these differences were not significant. Of the three subjects who answered question 2 incorrectly, none of them answered the follow-up question correctly, two answered incorrectly, and one participant was not asked a follow-up question. However, two of these same subjects answered question 3 correctly, which assesses the same component of opt-in testing consent. Generally, subjects reported a positive experience using the tablet kiosk as a means to give consent for HIV testing. A vast majority of subjects (83.9%, 95% CI: 78.8, 89.0) found the tablet kiosk very easy or easy to use, 89.4% (95% CI: 85.2, 93.7) reported they were very or mostly comfortable using the tablet kiosk to consent to HIV testing, and 77.9% (95% CI: 72.1, 83.7) of subjects liked using the kiosk to learn about the HIV testing and consent processes (Table 4) . Almost all subjects found the length of the informational program to be just right (95.0%, 95% CI: 91.9, 98.0) and agreed that the language and questions used in the program were very easy or easy to understand (95.0%, 95% CI: 91.9, 98.0). When asked their preference between using the tablet kiosk and speaking with a healthcare professional about HIV testing, 21.1% (95% CI: 15.4, 26.8) of subjects preferred using a tablet kiosk, 29.6% (95% CI: 23.3, 36.0) preferred a healthcare professional, and 48.7% (95% CI: 41.8, 55.7) of subjects reported they would prefer both or had no preference (Table 5 ). Among subjects who would prefer both or had no preference, some offered comments such as 'prefer to ask questions after using kiosk,' 'kiosk is more discreet,' and 'would like to ask follow up questions of HCW after using kiosk.'
Limitations
Data from this study should be interpreted with the following limitations in mind. First, the study design did not include a control group to which comparisons of consent comprehension rates could be made. In place of a control group, we sought similar studies within the literature by which to match comprehension rates. However, to our knowledge, there is no published data of the accuracy of patient comprehension of HIV consent to which findings from this study could be compared. A study with somewhat comparable outcomes 18 demonstrated that 97% of subjects reported they had been informed about HIV testing when an opt-in kiosk consent process was used, compared to 46% of subjects when an opt-out kiosk consent process was used. Researchers operationalized comprehension as a subjects' understanding of whether or not they had been informed about HIV testing. Patient self-report that they have been informed about HIV testing and HIV consent comprehension are associated; however, they are not analogous concepts. A second limitation of this study is the impact of potential selection bias, due to the use of a convenience sample. This restricted our sample to those patients who had been missed by the triage screening process or declined an HIV test at triage, so as to avoid the potential confound of having already consented to an HIV test during their ED visit. A final limitation is that literacy was not measured in our sample, which could impact the extent to which subjects are able to understand the material presented to them.
Discussion
In the last decade, EDs have increasingly implemented HIV testing programs to meet the CDC's 2006 recommendation for routine HIV screening for all persons 13 years and older. [2] [3] [4] Despite successes, many EDs encounter barriers to implementing a program streamlined with clinical care. An oft-cited barrier is the lengthy and elaborate consent process, for which touch screen tablet kiosks provide a novel solution.
We found an extraordinary rate of accurate comprehension of vital components of the HIV opt-in testing consent, including the voluntary nature of HIV testing (Q1: 93.0%, n ¼ 185) and that refusal of HIV testing would not impact patient care (Q2: 98.5%, n ¼ 196; Q3: 99.0%, n ¼ 197). This demonstration of high levels of opt-in consent comprehension using a tablet kiosk provides an innovative solution for the barriers encountered when implementing HIV screening into existing ED clinical workflows. Although these findings are significant in their own right, it is of note that this study assessed patient comprehension of HIV consent in a highly structured experiment without the complications of clinical and patient flow in a high volume episodic care center.
Several pilot proof-of-concept studies for using kiosks in the context of HIV have been performed in non-ED settings. In a study of kiosk-based HIV education in a primary care setting, authors concluded that kiosks are effective tools for delivering targeted HIV screening information. 23 Other non-HIV-related studies are also relevant to our project. One food safety education study, conducted in a primarily African American population, found that individuals with no college education preferred learning through kiosks over pamphlets and found that patients expressed significant interest in learning about other subject areas through kiosks. 24 Findings from our study furthermore demonstrate high rates of patient acceptability for a tablet kioskfacilitated consent process, the first study to demonstrate the acceptability of kiosks for HIV opt-in testing consent. Subjects were comfortable using the tablet kiosk during the simulated HIV consent process, found the tablet kiosk easy to use, and reported a positive experience using the tablet kiosk to learn about and provide opt-in consent for HIV testing. Previous studies from our ED and elsewhere have demonstrated the acceptability and feasibility of using kiosks for patient registration and screening, 25 offering HIV testing, 21 improving patient flow, 26 providing patients with information regarding public health interventions, 27, 28 and providing patient education. [29] [30] [31] Further studies could explore the optimization of tablets/kiosks by fully integrating them into clinical flow and the EMR system, which was beyond the scope of this pilot study. Jones 26 recommended that kiosks be integrated with services in order for kiosks to succeed in healthcare settings. Ideally, a comprehensive tablet kiosk system could be used at triage for patient registration (including providing insurance and billing information), 32 offer (opt-in or opt-out) HIV testing to eligible patients, provide pretest counseling information, obtain consent for an HIV test, and automatically trigger a test order when a patient consents. Preferably, this process could occur before a patient is even medically triaged by a nurse. The faceto-face triage interaction could then give the patient an opportunity to ask any questions regarding the HIV testing process and the potential to self-collect an oral swab for POC testing under supervision ED nurse or clinician. Implementation of this new kiosk-based system could examine if HIV testing rates increased and if hands-on time required of ED staff decreased as a result of this new system. Future studies could seek to clarify our understanding of comprehension rates by incorporating a control group and examining the impact of two additional concepts. From this pilot study, it is unclear whether comprehension rates change when patients know they are undergoing a simulated mock consent process. This could be explored in a future study by comparing comprehension rates of patients who undergo a mock consent via kiosk compared with those who undergo a standard consent via the kiosk approach. Future studies could also explore how literacy, in addition to computer use, impacts comprehension of the required aspects of HIV testing consent.
Of note, the state of Maryland has now moved away from opt-in consent and opt-out consent for HIV testing has become standard at our institution. This updated law and policy does not affect the potential utility of tablet kiosks for HIV consent. In fact, with a simple language change our tablet kiosk could be used for opt-out HIV testing consent. Furthermore, many states and institutions continue to use opt-in consent for HIV testing, along with international healthcare organizations. 33 
Conclusions
In summary, our study aimed to explore the alleviation of barriers associated with HIV testing consent by leveraging the novel technology of a tablet kiosk. We found high rates of consent comprehension for all aspects of HIV testing consent required by state law and our institution. Additionally, patients reported high acceptability of using the tablet kiosk for consent, noting 'kiosks are more private.' Utilization of this technology need not stop at HIV testing consent, as consent for medical procedures or research studies could be improved with tablet kiosks.
